A Retrospective Analysis of the Significance of Haemoglobin SS and SC in Disease Outcome in Patients With Sickle Cell Disease and Dengue Fever

EBioMedicine

Volumn 2, Issue 8, 2015, Pages 937-941

  Rankine Mullings, Angela ^a   Reid, Marvin E ^a   Moo Sang, Michelle ^a   Richards Dawson, Michelle Ann ^b   Knight Madden, Jennifer M ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b Bustamante Hospital for Children   (Jamaica)

Author keywords

Dengue; Sickle

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN M; HEMOGLOBIN S;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; CHILD; CLINICAL ARTICLE; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEMOGLOBIN SC DISEASE; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; YOUNG ADULT; BLOOD; CLINICAL TRIAL; GENETICS; HETEROZYGOTE; HOMOZYGOTE; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; DENGUE; FEMALE; HEMOGLOBIN, SICKLE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 84951573360     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.07.002     Document Type: Article

References (22)

1. Asnani M., Bhatt K., Cumming V., et al. Sickle Cell Disease - The Clinical Care Guidelines of the Sickle Cell Unit 2008, (October, 123 p.). S. Ali (Ed.).
2. Banu S., Hu W., Guo Y., Naish S., Tong S. Dynamic spatiotemporal trends of dengue transmission in the Asia-Pacific region, 1955-2004. PLoS One 2013, 9:e89440.
3. Bravo J.R., Guzman M.G., Kouri G.P. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans. R. Soc. Trop. Med. Hyg. 1987, 81(5):816-820. (Epub 1987/01/01).
4. Brown M.G., Vickers I.E., Salas R.A., Smikle M.F. Seroprevalence of dengue virus antibodies in healthy Jamaicans. Hum. Antibodies 2009, 18(4):123-126.
5. Centers for Disease Control and Prevention Dengue Available from. http://www.cdc.gov/Dengue/.
6. Hannemann A., Weiss E., Rees D.C., Dalibalta S., Ellory J.C., Gibson J.S. The properties of red blood cells from patients heterozygous for HbS and HbC (HbSC genotype). Anemia 2011, 2011:248527. (Epub 2011/04/15).
7. Kosmidis I., Firth D. Bias reduction in exponential family nonlinear models. Biometrika 2009, 4:793-804.
8. Limonta D., Gonzalez D., Capo V., et al. Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic. Int. J. Infect. Dis. 2009, 13(2):e77-e78. (Epub 2008/10/14).
9. Makani J., Ofori-Acquah S.F., Nnodu O., Wonkam A., Ohene-Frempong K. Sickle cell disease: new opportunities and challenges in Africa. Sci. World J. 2013, 2013:193252.
10. Ministry of Health Kingston Jamaica Dengue Fever Surveillance Protocol 2012, (Revised October 12).
11. Moesker F.M., Muskiet F.D., Koeijers J.J., Fraaij P.L., Gerstenbluth I., van Gorp E.C., et al. Fatal dengue in patients with sickle cell disease or sickle cell anemia in Curacao: two case reports. PLoS Negl. Trop. Dis. 2013, 7(8):e2203. (Epub 2013/08/21).
12. Musa B.O., Onyemelukwe G.C., Hambolu J.O., Mamman A.I., Isa A.H. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis. Clin. Vaccine Immunol. 2010, 17(4):602-608. (Epub 2010/02/05).
13. Nagel R.L., Fabry M.E., Steinberg M.H. The paradox of hemoglobin SC disease. Blood Rev. 2003, 17(3):167-178. (Epub 2003/06/24).
14. Ong S.P., Lee L.M., Leong Y.F., Ng M.L., Chu J.J. Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells. PLoS One 2012, 7(7):e41932. (Epub 2012/08/04).
15. Peeling R.W., Artsob H., Pelegrino J.L., et al. Evaluation of diagnostic tests: dengue. Nature Reviews Microbiology 2010.
16. Remy M.M. Dengue fever: theories of immunopathogenesis and challenges for vaccination. Inflamm. Allergy Drug Targets 2014, 13(4):262-274. (Epub 2014/08/29).
17. Serjeant G.R. Observations on the epidemiology of sickle cell disease. Trans. R. Soc. Trop. Med. Hyg. 1981, 75(2):228-233. (Epub 1981/01/01).
18. Serjeant G. Sickle haemoglobin comes of age. Lancet Glob. Health 2014, 2(2):e59-e60.
19. Special Programme for Research & Training in Tropical Diseases (TDR) sponsored by UNICEF/UNDP/World Bank/WHO Evaluation of commercially available anti-dengue virus immunoglobulin M tests 2009, World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR).
20. Wang S.M., Sekaran S.D. Early diagnosis of dengue infection using a commercial dengue duo rapid test kit for the detection of NS1, IGM, and IGG. Am. J. Trop. Med. Hyg. 2010, 83(3):690-695.
21. World Health Organization Impact of dengue [World Wide Web] 2014 [cited 2014 1st August]; available from. http://www.who.int/csr/disease/dengue/impact/en/.
22. Xu H., Wandersee N.J., Guo Y., Jones D.W., Holzhauer S.L., Hanson M.S., et al. Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation. Blood 2014, 124(26):3978-3981. (Epub 2014/10/24).